<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "JATS-journalpublishing1.dtd">
<article article-type="abstract" dtd-version="1.0" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CC</journal-id>
<journal-id journal-id-type="nlm-ta">Cardiol Croat</journal-id>
<journal-title-group>
<journal-title>Cardiologia Croatica</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Cardiol. Croat.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1848-543X</issn>
<issn pub-type="epub">1848-5448</issn>
<publisher><publisher-name>Croatian Cardiac Society</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">CC 2022 17_9-10_252</article-id>
<article-id pub-id-type="doi">10.15836/ccar2022.252</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Extended Abstract</subject></subj-group>
<subj-group subj-group-type="subheading"><subject>Cardiovascular prevention and rehabilitation</subject></subj-group>
</article-categories>
<title-group>
<article-title>Cardiac rehabilitation in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9743-9201</contrib-id><name><surname>Raljevi&#x0107;</surname><given-names>Damir</given-names></name><xref ref-type="corresp" rid="cor1">*</xref></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0207-8712</contrib-id><name><surname>Bebi&#x0107;</surname><given-names>Lovro</given-names></name></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0627-2114</contrib-id><name><surname>Matijevi&#x0107; Ron&#x010D;evi&#x0107;</surname><given-names>Sanja</given-names></name></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8921-7999</contrib-id><name><surname>Pehar Pej&#x010D;inovi&#x0107;</surname><given-names>Vesna</given-names></name></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6238-3738</contrib-id><name><surname>Travica Samsa</surname><given-names>Dijana</given-names></name></contrib>
<contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4473-5431</contrib-id><name><surname>Per&#x0161;i&#x0107;</surname><given-names>Viktor</given-names></name></contrib>
<aff id="aff1"><institution>Special Hospital for Medical Rehabilitation of the Heart and Lung Diseases and Rheumatism &#x201C;Thalassotherapia Opatija&#x201D;</institution>, <addr-line>Opatija</addr-line>, <country country="hr">Croatia</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>ADDRESS FOR CORRESPONDENCE: Damir Raljevi&#x0107;, Thalassotherapia Opatija, M. Tita 188/1, HR-51410 Opatija, Croatia. / Phone: +385-91-5970-296 / E-mail: <email xlink:href="damir.raljevic@gmail.com">damir.raljevic@gmail.com</email></corresp></author-notes>
<pub-date pub-type="epub-ppub"><month>11</month><year>2022</year></pub-date>
<volume>17</volume>
<issue>9-10</issue>
<fpage>252</fpage>
<lpage>252</lpage>
<history>
<date date-type="received"><day>03</day><month>11</month><year>2022</year></date>
<date date-type="accepted"><day>10</day><month>11</month><year>2022</year></date>
</history>
<permissions>
<copyright-year>2022</copyright-year>
<copyright-holder>Croatian Cardiac Society</copyright-holder>
</permissions>
<kwd-group kwd-group-type="author"><title>KEYWORDS: </title><kwd>cardiac rehabilitation</kwd><kwd>cardiac resynchronization therapy</kwd><kwd>implantable cardioverter defibrillator</kwd></kwd-group>
</article-meta>
</front>
<body>
<p><bold>Introduction:</bold> There is a large body of evidence that supports the positive effect of exercise based cardiac rehabilitation on reducing mortality, hospitalization rate and increasing the quality of life and exercise capacity in patients with heart failure. Also, there is more evidence about the positive effect of cardiac resynchronization therapy (CRT) and implantable cardioverter defibrillator (ICD) in patients with heart failure with reduced ejection fraction and interventricular conduction abnormalities in reducing mortality, increasing quality of life and exercise capacity. (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>, <xref ref-type="bibr" rid="r2"><italic>2</italic></xref>) The aim of this review is to determine the existence of an additive effect of the exercise cardiac rehabilitation program in CRT patients on the increase in functional capacity. Also, the aim of this review is to establish the safety of the exercise based cardiac rehabilitation program in ICD patients regarding to anti-tachycardia pacing, appropriate and inappropriate ICD shocks.</p>
<p><bold>Methods</bold>: Systematic review of available scientific literature and discussion of collected data.</p>
<p><bold>Results</bold>: CRT therapy, in addition to optimal drug therapy, is a well-established treatment method in patients with heart failure with reduced left ventricular ejection fraction and intraventricular conduction abnormalities. Several randomized controlled studies and meta-analyses have established the association of exercise based cardiac rehabilitation with an additional increase in aerobic exercise capacity measured by VO<sub>2</sub> max and improvement in quality of life in CRT patients. (<xref ref-type="bibr" rid="r1"><italic>1</italic></xref>) Furthermore, several RCTs and meta-analyses have confirmed an increase in aerobic exercise capacity and quality of life in ICD patients without affecting mortality, serious adverse events, the number of anti-tachycardia pacing, appropriate and inappropriate ICD shocks. (<xref ref-type="bibr" rid="r2"><italic>2</italic></xref>)</p>
<p><bold>Conclusion</bold>: Well-managed exercise based cardiac rehabilitation programs show an additive effect on CRT therapy in increasing aerobic functional capacity and increasing quality of life with a good safety profile without affecting mortality, episodes of anti-tachycardia pacing, appropriate and inappropriate ICD shocks.</p>
</body>
<back>
<ref-list>
<title>LITERATURE</title>
<ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grosman-Rimon</surname><given-names>L</given-names></name><name><surname>Hui</surname><given-names>S</given-names></name><name><surname>Santos</surname><given-names>S</given-names></name><name><surname>Vadasz</surname><given-names>B</given-names></name><name><surname>Foroutan</surname><given-names>F</given-names></name><name><surname>Farrell</surname><given-names>A</given-names></name><etal/></person-group> <article-title>Exercise rehabilitation in cardiac resynchronization: systematic review and a meta-analysis.</article-title> <source>Heart Fail Rev</source>. <year>2021</year> May;<volume>26</volume>(<issue>3</issue>):<fpage>507</fpage>&#x2013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1007/s10741-020-10049-7</pub-id><pub-id pub-id-type="pmid">33200311</pub-id></mixed-citation></ref>
<ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nielsen</surname><given-names>KM</given-names></name><name><surname>Zwisler</surname><given-names>AD</given-names></name><name><surname>Taylor</surname><given-names>RS</given-names></name><name><surname>Svendsen</surname><given-names>JH</given-names></name><name><surname>Lindschou</surname><given-names>J</given-names></name><name><surname>Anderson</surname><given-names>L</given-names></name><etal/></person-group> <article-title>Exercise-based cardiac rehabilitation for adult patients with an implantable cardioverter defibrillator.</article-title> <source>Cochrane Database Syst Rev</source>. <year>2019</year> February 12;<volume>2</volume>(<issue>2</issue>):<elocation-id>CD011828</elocation-id>. <pub-id pub-id-type="doi">10.1002/14651858.CD011828.pub2</pub-id><pub-id pub-id-type="pmid">30746679</pub-id></mixed-citation></ref>
</ref-list>
</back>
</article>
